关注
Shuli Qu
Shuli Qu
US CDC; IMS Health; IQVIA; University of Michigan
在 iqvia.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the community …
R Li, S Qu, P Zhang, S Chattopadhyay, EW Gregg, A Albright, D Hopkins, ...
Annals of internal medicine 163 (6), 452-460, 2015
1942015
Publicized sobriety checkpoint programs: a community guide systematic review
G Bergen, A Pitan, S Qu, RA Shults, SK Chattopadhyay, RW Elder, ...
American journal of preventive medicine 46 (5), 529-539, 2014
842014
Effects of mental health benefits legislation: a community guide systematic review
TA Sipe, RKC Finnie, JA Knopf, S Qu, JA Reynolds, AB Thota, RA Hahn, ...
American journal of preventive medicine 48 (6), 755-766, 2015
452015
Out-of-school-time academic programs to improve school achievement: A community guide health equity systematic review
JA Knopf, RA Hahn, KK Proia, BI Truman, RL Johnson, C Muntaner, ...
Journal of Public Health Management and Practice 21 (6), 594-608, 2015
392015
Assessing the burden of type 2 diabetes in China considering the current status-quo management and implications of improved management using a modeling approach
V Foos, K Wang, P McEwan, Y Zhang, P Xin, X Jiang, S Qu, T Xiong, ...
Value in Health Regional Issues 18, 36-46, 2019
212019
Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal …
P Men, S Qu, W Luo, C Li, S Zhai
Diabetes, Obesity and Metabolism 22 (1), 107-115, 2020
172020
Economic effects of legislations and policies to expand mental health and substance abuse benefits in health insurance plans: A community guide systematic review
V Jacob, S Qu, S Chattopadhyay, TA Sipe, JA Knopf, RZ Goetzel, R Finnie, ...
The journal of mental health policy and economics 18 (1), 39, 2015
162015
A Caprini risk score-based cost-effectiveness analysis of enoxaparin for the thromboprophylaxis of patients after nonorthopedic surgery in a Chinese healthcare setting
Y Bao, G Zhao, S Qu, T Xiong, X Yao, B Wu
Clinical Drug Investigation 40, 161-171, 2020
152020
High school completion programs: a community guide systematic economic review
S Qu, SK Chattopadhyay, RA Hahn, ...
Journal of Public Health Management and Practice 22 (3), E47-E56, 2016
152016
Cost-effectiveness of flash glucose monitoring for the management of patients with type 1 and patients with type 2 diabetes in China
X Zhao, J Ming, S Qu, HJ Li, J Wu, L Ji, Y Chen
Diabetes Therapy 12, 3079-3092, 2021
142021
Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost …
P Men, Z Yi, C Li, S Qu, T Xiong, X Yu, S Zhai
BMC psychiatry 18, 1-15, 2018
122018
Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and …
X Hu, S Qu, X Yao, C Li, Y Liu, J Wang
Cost Effectiveness and Resource Allocation 17, 1-10, 2019
112019
Comparative clinical effects and cost–effectiveness of maximum androgen blockade, docetaxel with androgen deprivation therapy and ADT alone for the treatment of mHSPC in China
M Liu, S Qu, Y Liu, X Yao, W Jiang
Journal of Comparative Effectiveness Research 8 (11), 865-877, 2019
112019
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
S Qu, X You, T Liu, L Wang, Z Yin, Y Liu, C Ye, T Yang, M Huang, H Li, ...
NPJ Primary Care Respiratory Medicine 31 (1), 28, 2021
102021
Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis
P Men, S Qu, Z Song, Y Liu, C Li, S Zhai
Diabetes Therapy 11, 1745-1755, 2020
92020
Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
Z Wang, R Sun, Y Sheng, S Qu, L Dong, B Wu
Annals of Translational Medicine 10 (8), 2022
82022
Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china
J Cui, X Zhang, S Qu, L Wang
Expert Review of Pharmacoeconomics & Outcomes Research 21 (4), 691-697, 2021
82021
Prostate cancer screening using prostate-specific antigen tests in a high-risk population in China: A cost-utility analysis
X Qin, D Ye, C Gu, Y Huang, W Gu, B Dai, H Zhang, Y Zhu, H Yang, S Qu
Current Therapeutic Research 95, 100653, 2021
42021
Comparison of abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer (mHSPC): An updated network meta …
X Hu, X Yao, C Li, Y Liu, T Xiong, S Qu, J Wang
Journal of Clinical Oncology 36 (15_suppl), e17008-e17008, 2018
22018
Meta-analysis of the epidemiology of microvascular complications in people with Type 2 diabetes in mainland China
Y CHENG, QU Shuli, LIU Yanjun, Y ZHANG, XU Wenjie, C Li
Global Journal of Obesity, Diabetes and Metabolic Syndrome 7 (2), 018-023, 2020
12020
系统目前无法执行此操作,请稍后再试。
文章 1–20